Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 833

Similar articles for PubMed (Select 12112477)

1.
2.

Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.

Liu F, Woitge HW, Braut A, Kronenberg MS, Lichtler AC, Mina M, Kream BE.

Int J Dev Biol. 2004 Sep;48(7):645-53.

3.

Collagen1alpha1 promoter drives the expression of Cre recombinase in osteoblasts of transgenic mice.

Zha L, Hou N, Wang J, Yang G, Gao Y, Chen L, Yang X.

J Genet Genomics. 2008 Sep;35(9):525-30. doi: 10.1016/S1673-8527(08)60072-7.

PMID:
18804071
4.

[Establishment of osteoblast-specific Cre transgenic mice].

Cheng X, Weng TJ, Tan XH, Hou N, Wang J, Lin FY, Huang PT, Yang X.

Yi Chuan. 2007 Oct;29(10):1237-42. Chinese.

PMID:
17905714
5.

Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.

Licht AH, Raab S, Hofmann U, Breier G.

Dev Dyn. 2004 Feb;229(2):312-8.

6.

Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.

Ray MK, Fagan SP, Moldovan S, DeMayo FJ, Brunicardi FC.

J Surg Res. 1999 Jun 15;84(2):199-203.

PMID:
10357920
7.

Stage-and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice.

Sakai K, Hiripi L, Glumoff V, Brandau O, Eerola R, Vuorio E, Bösze Z, Fässler R, Aszódi A.

Matrix Biol. 2001 Jan;19(8):761-7.

PMID:
11223335
8.

Specific Cre/Lox recombination in the mouse proximal tubule.

Rubera I, Poujeol C, Bertin G, Hasseine L, Counillon L, Poujeol P, Tauc M.

J Am Soc Nephrol. 2004 Aug;15(8):2050-6.

9.

A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.

Ray MK, Fagan SP, Moldovan S, DeMayo FJ, Brunicardi FC.

Biochem Biophys Res Commun. 1998 Dec 9;253(1):65-9.

PMID:
9875221
10.

Cre-mediated transgene activation in the developing and adult mouse brain.

Cinato E, Mirotsou M, Sablitzky F.

Genesis. 2001 Nov;31(3):118-25.

PMID:
11747202
11.

Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.

Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M.

Dev Biol. 2001 Feb 15;230(2):230-42.

12.

Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.

Ray MK, Fagan SP, Moldovan S, DeMayo FJ, Brunicardi FC.

Int J Pancreatol. 1999 Jun;25(3):157-63.

PMID:
10453417
13.

Neural expression of alpha-internexin promoter in vitro and in vivo.

Wang P, Wang SM, Hsieh CJ, Chien CL.

J Cell Biochem. 2006 Feb 1;97(2):275-87.

PMID:
16173078
14.

Transgenic mice that express Cre recombinase in hypertrophic chondrocytes.

Yang G, Cui F, Hou N, Cheng X, Zhang J, Wang Y, Jiang N, Gao X, Yang X.

Genesis. 2005 May;42(1):33-6.

PMID:
15830383
15.

[Establishment of hypertrophic chondrocytes-specific Cre transgenic mice].

Hou N, Yang G, Fan XW, Wu XS, Yang X.

Yi Chuan. 2009 Jan;31(1):69-74. Chinese.

PMID:
19138904
16.
17.

Inflamed glomeruli-specific gene activation that uses recombinant adenovirus with the Cre/loxP system.

Yokoo T, Ohashi T, Utsunomiya Y, Shiba H, Shen JS, Hisada Y, Eto Y, Kawamura T, Hosoya T.

J Am Soc Nephrol. 2001 Nov;12(11):2330-7.

18.

Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors.

Ahmed BY, Chakravarthy S, Eggers R, Hermens WT, Zhang JY, Niclou SP, Levelt C, Sablitzky F, Anderson PN, Lieberman AR, Verhaagen J.

BMC Neurosci. 2004 Jan 30;5:4.

19.

Podocyte-specific expression of cre recombinase in transgenic mice.

Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB.

Genesis. 2003 Jan;35(1):39-42.

PMID:
12481297
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk